News for Healthier Living

Automation of Nuclear Chemistry Processes Leads to More Efficient Production of Astatine for Cancer Therapy

Astatine-211 (At-211) is a promising alpha emitting radioisotope for cancer therapy, but its short 7.2-hour half-life means that it must be handled quickly to minimize losses due to radioactive decay. In this research, scientists designed and tested an automated device for producing At-211 that improves production time and efficiency. The device also minimizes the dose of radioactivity to production staff and reduces the time needed to prepare samples for shipment.

December 20, 2024


January 1 2025

December 31 2024

December 30 2024

December 29 2024

December 28 2024

December 27 2024

December 26 2024

December 24 2024

December 23 2024

December 21 2024

December 20 2024

December 19 2024